Kyle Kline
CIK 2080625 · Senior Vice President, CFO · last filed 2026-01-23
Kyle Kline is a Senior Vice President, CFO who has filed 7 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for GMED, was dated Jan 23, 2026. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $309.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$309.6K
1
7
-$2.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Senior Vice President, CFO | 3,594 | $86.15 | $309.6K | -$2.03M | 5 | 2026-01-23 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | GMED | Grant (A) | — | $0 | EDGAR |
| 2026-01-13 | GMED | Exer (M) | — | $0 | EDGAR |
| 2026-01-12 | GMED | Mixed | — | -$176.9K | EDGAR |
| 2026-01-08 | GMED | Notice (144) | −3,594 | -$363.2K | EDGAR |
| 2025-12-03 | GMED | Mixed | — | -$558.9K | EDGAR |
| 2025-12-01 | GMED | Notice (144) | −18,542 | -$1.67M | EDGAR |
| 2025-08-27 | GMED | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.